The firm owned 30,451 shares of the company’s stock after selling 4,562 shares during the quarter. Chatham Capital Group Inc.’s holdings in AbbVie were worth $5,652,000 at the end of the most recent quarter. Goldman Sachs Group Inc. increased its stake in shares of AbbVie by 31.6% in the first quarter. Kingstone Capital Partners Texas LLC acquired a new position in shares of AbbVie during the 2nd quarter worth about $581,817,000. Get AbbVie alerts:Insider ActivityIn other AbbVie news, EVP Azita Saleki-Gerhardt sold 42,370 shares of AbbVie stock in a transaction on Tuesday, August 12th.